News & analysis of healthcare, pharma and biotech. Magazines, directories, profiles, jobs & awards.
Surrey, UK
Joined June 2009
- Tweets22.5K
- Following3.3K
- Followers15.7K
- Likes347
Agentic commercial: AI redefines field, digital and content for precision engagement pmlive.com/pharma_thought_le…
Fresenius and WuXi Biologics announce agreement to expand biosimilars pipeline pmlive.com/pharma_news/frese…
The invisible influencer: the new information layer between doctors and scientific evidence pmlive.com/pharma_thought_le…
AbbVie expands Oxford R&D as part of more than £120m investment in UK life sciences pmlive.com/pharma_news/abbvi…
Navigating uncertainty in life sciences pmlive.com/pmhub/inizio/navi…
Creating the conditions for product launch success in a time of volatility pmlive.com/pmhub/inizio/crea…
How pharma companies can use AI to scale personalized engagement without increasing complexity pmlive.com/pmhub/inizio/how-…
Inizio appoints Oisín Ó Gógáin as Chief People Officer pmlive.com/pmhub/inizio/iniz…
The future of science communication is already on social pmlive.com/pharma_thought_le…
Karyopharm announces planned merger with Ayrmid amid Chapter 11 bankruptcy filing pmlive.com/pharma_news/karyo…
Veradermics announces phase 3 results for oral minoxidil for hair loss pmlive.com/veradermics-annou…
Trust doesn’t travel through channels. It travels through people pmlive.com/pharma_thought_le…
Using the power of social media to break down obstacles preventing improved patient engagement pmlive.com/intelligence/usin…
Winning takes more than innovation – it requires an ecosystem ready to adopt it pmlive.com/pharma_thought_le…
Medscape Education Receives National Scleroderma Foundation’s Rocky Mountain Chapter’s “Partner of Hope Award” for Empowering the Patient Voice and Shortening the Diagnostic Journey pmlive.com/pmhub/medscape_ed…
Eli Lilly names Ilya Yuffa as executive vice president and president, Lilly Global Markets pmlive.com/pharma_appointmen…
DEBRA Research joins with Topadur to advance therapies for dystrophic epidermolysis bullosa pmlive.com/pharma_news/debra…
MHRA approves new oral treatment for moderate-to-severe plaque psoriasis pmlive.com/pharma_news/mhra-…
Novartis presents positive results from two phase 3 trials for relapsing MS pmlive.com/pharma_news/novar…
